Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

about

Advances in the proteomic discovery of novel therapeutic targets in cancer.Triggering of suicidal erythrocyte death by celecoxib.

P2860

Q37260569-77794D30-EEE8-4107-BF99-1F9002FDF158 Q42146863-6DF8F22A-F87B-4F5A-934D-567A3B47D8C8

P2860

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

Item

http://www.wikidata.org/entity/Q36100952

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

@ast

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

@en

type

Item

label

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

@ast

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

@en

prefLabel

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

@ast

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

@en

P1476

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

@en

P2093

Florastina Payton-Stewart

http://www.w3.org/2001/XMLSchema#string

Leyte L Winfield

http://www.w3.org/2001/XMLSchema#string

P2860

Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands

Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix.

Role of cyclooxygenase-2 in colorectal cancer

A cyclooxygenase-2 inhibitor (SC-58125) blocks growth of established human colon cancer xenografts

BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells

The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues

Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala

Cyclooxygenase-2-dependent phosphorylation of the pro-apoptotic protein Bad inhibits tonicity-induced apoptosis in renal medullary cells

Role of cyclooxygenase-2 in colorectal cancer

The Bcl-2 protein family: arbiters of cell survival

P304

361-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.11.177

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221680892

http://www.w3.org/2001/XMLSchema#string

P698

22393942

http://www.w3.org/2001/XMLSchema#string

P932

3398981

http://www.w3.org/2001/XMLSchema#string

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

about

P2860

P2860

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932